Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease.
about
The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inceptionThe Alzheimer's disease neuroimaging initiative: progress report and future plans2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects.New tools for the study of Alzheimer's disease: what are biomarkers and morphometric markers teaching us?Regional cortical thinning and cerebrospinal biomarkers predict worsening daily functioning across the Alzheimer's disease spectrum.The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairmentShould we disclose amyloid imaging results to cognitively normal individuals?Everyday cognition scale items that best discriminate between and predict progression from clinically normal to mild cognitive impairmentCerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment.Biomarkers of the dementia.Does CSF p-tau181 help to discriminate Alzheimer's disease from other dementias and mild cognitive impairment? A meta-analysis of the literature.Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.For debate: substituting placebo controls in long-term Alzheimer's prevention trials.Self-rated and informant-rated everyday function in comparison to objective markers of Alzheimer's disease.Functional Activities Questionnaire Items that Best Discriminate and Predict Progression from Clinically Normal to Mild Cognitive ImpairmentEstimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative.Human Alzheimer and inflammation biomarkers after anesthesia and surgery.Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease?Biomarkers of basic activities of daily living in Alzheimer's disease.High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease.Cerebrospinal Fluid Biomarkers and Reserve Variables as Predictors of Future "Non-Cognitive" Outcomes of Alzheimer's Disease.Potential fluid biomarkers for pathological brain changes in Alzheimer's disease: Implication for the screening of cognitive frailty.CSF biomarkers of Alzheimer disease: "noncognitive" outcomes.Postoperative cognitive changes after total knee arthroplasty under regional anesthesia.Plasma amyloid-β levels and prognosis in incident dementia cases of the 3-City StudyCerebrospinal fluid biomarkers for Alzheimer's disease: the present and the future.CSF biomarkers for amyloid and tau pathology in Alzheimer's disease.A qualitative review of instrumental activities of daily living in dementia: what's cooking?Biomarkers and Functional Decline in Prodromal Alzheimer's Disease.Biomarkers in Parkinson's disease: a funder's perspective.Tau protein and beta-amyloid(1-42) CSF levels in different phenotypes of Parkinson's disease.Informants' Perception of Subjective Cognitive Decline Helps to Discriminate Preclinical Alzheimer's Disease from Normal Aging.Mild cognitive impairment (MCI) twenty years on.Simultaneous assessment of cognitive function, circadian rhythm, and spontaneous activity in aging mice.Online study partner-reported cognitive decline in the Brain Health Registry
P2860
Q27006831-956AB94D-91C5-4557-848C-82558D7EB67EQ28749585-346FF6D3-C71A-41C1-82EA-4FD88C4247BDQ30971403-9FE3E997-1007-4C88-B08B-015082E96E37Q33842486-2D1B05C5-3856-4AB1-A0C6-CDF24F96D595Q33881726-920F8E1E-965B-4555-BCC3-5EC46055C10BQ33953180-A22B4E8D-8F9A-45F8-9B3D-66041CD85D04Q34065449-BA5983BB-08D4-4882-BD18-28CCC30A0B9EQ34180267-5F736497-9D1A-4F2B-B178-8CE9542121EAQ34286140-AAB29EE8-8082-41DC-AADF-4FF42A1CBBF8Q34587724-634637C0-0B93-4663-8661-A3C9CA9FB229Q34679106-0AD527BA-B3C2-4C1C-A7F9-DE2269D18578Q35030049-A1122B5E-1D9C-4E93-90A7-38BE645D38CCQ35166684-E12D7799-129B-41D3-8F61-06007AEAF25BQ35497573-ADD3B643-95F1-429D-AE76-07C10E053E7EQ35579221-2F43656A-781A-43D3-ACFA-0F1651C93809Q35611460-1CB05943-BBD9-4219-8443-6A1663556B7AQ35662685-C6201CF7-F6A0-4584-B7B7-F38B492B6DE0Q36143793-0B3116FA-7495-4E1E-B898-920A383EA962Q36194462-247E2D3D-7182-4F42-8F13-7F615FE2E5C4Q36755789-BDC95C8C-B3C4-4201-9061-8F306F241FF2Q36818214-C2263127-4C49-491A-B468-55E558FDF6B4Q36970998-6D29CC0C-AAD0-4822-A191-9DE356DB0209Q37272348-2E680010-3C18-4F91-9CCE-AA8BDB4E0A1EQ37297626-02A2E0C8-5DAA-492F-B3D1-14AA548E5877Q37372440-86DAC7A3-430F-4EF0-88DB-30788C20EDB3Q37552102-B5A1E421-26DF-4BD0-A254-CB057F3971C8Q37693190-BE158158-EEBE-4161-9631-3DF8CE481A06Q37895052-64BD6C1C-C7FC-4F44-A9F3-AF7DF2BBC250Q37953330-6CA8220C-33A7-44F8-8CF2-889C7DA78047Q38269098-3D3577A3-E82F-4361-94FE-1F057F396625Q38858239-17429816-EADD-49D6-B123-C375D5881B78Q39827858-471E016C-100F-4479-A1B6-C9C8A2AC05C4Q50262786-30D7EC3C-6E89-4F1B-AC96-E603453AD618Q50560838-06451E81-C6B1-406C-B6B1-5A0D7A450038Q54000552-6984BE6A-C05C-4043-8D08-C6FF74E30FDAQ55050089-20939CB1-8DDF-4BA1-BB20-1946B8699868Q58560363-508C76FB-E4EE-4261-9F08-6AE12D01EB3A
P2860
Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cerebrospinal fluid abnormalit ...... irment, and Alzheimer disease.
@ast
Cerebrospinal fluid abnormalit ...... irment, and Alzheimer disease.
@en
type
label
Cerebrospinal fluid abnormalit ...... irment, and Alzheimer disease.
@ast
Cerebrospinal fluid abnormalit ...... irment, and Alzheimer disease.
@en
prefLabel
Cerebrospinal fluid abnormalit ...... irment, and Alzheimer disease.
@ast
Cerebrospinal fluid abnormalit ...... irment, and Alzheimer disease.
@en
P2093
P2860
P1433
P1476
Cerebrospinal fluid abnormalit ...... irment, and Alzheimer disease.
@en
P2093
Geoffrey Tremont
H Randall Griffith
Leslie M Shaw
Michael L Alosco
Michelle M Mielke
Ozioma C Okonkwo
P2860
P304
P356
10.1001/ARCHNEUROL.2010.118
P577
2010-06-01T00:00:00Z